$IMLFF The company's manufacturing technology will provide the compounds needed to research and commercialize their internal product candidates; however, it is estimated that the market for CBD alone, as an ingredient for mixing into other products, will surpass $2B by 2020. This manufacturing capability could very well be a huge stand-alone business opportunity for InMed.

Please follow the link to see the interview with CEO Eric A. Adams and read the full article: http://www.cannabisfn.com/inmed-pharma-develo...roduction/

https://finance.yahoo.com/news/inmed-pharma-c...00706.html

$VBIO $GWPH $AXIM